Credo is the world leading SerDes Technology Company offers silicon proven SerDes IP from 1G to 112G data rate. Features include excellent insertion loss handling for commuication applications; ...
Aviva Links makes standards-based asymmetrical multi-gigabit serial/deserialiser (SerDes) for the Automotive SerDes Alliance (ASA) standard for interoperable network architecture. These support ...
Daiichi will invest 1.1 billion Chinese yuan ($152 million) to build a new antibody-drug conjugate (ADC) manufacturing facility in Shanghai, the Japanese pharma said (Chinese), on the heels of ...
Westford,USA, Dec. 10, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that SerDes Market size will attain the value of USD 1,421.23Million by 2031, with a CAGR of 8.13% during the forecast period ...
The “scientific trailblazer” behind Daiichi Sankyo’s blockbuster ADC medicines, Toshinori Agatsuma, has passed away, the company said Monday.
Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the ...
AstraZeneca and Daiichi Sankyo have unveiled new data on their TROP2-directed ADC in pretreated lung cancer patients with EGFR-mutated disease, adding to their case for … ...
Gender-based violence is among the most widespread human rights violations globally. As the 16 Days of Activism campaign reminds us, it demands urgent and collective action. UNDP is on the ground ...
Of the 22 guru strategies we follow, ADC rates highest using our Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent ...
PCR-based techniques are methods that rely on the polymerase chain reaction (PCR) to amplify stretches of DNA by creating many identical or near-identical copies. For example, PCR amplification ...